Top 10 at 10: Who’s planning to tap a $6bn Chinese market?

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Tiny data centre stock DXN (ASX:DXN) had negative operating cash flow for the June quarter, but new contracts with Pilbara Minerals (ASX:PLS) and Anglo-American will “generate cash inflows for the modular manufacturing business over the next 3 quarters”.

Medtech Osteopore (ASX:OSX) inked a non-binding deal to manufacture and sell its regenerative medicine technology applications in China.

Currently worth ~$6bnpa, regenerative medicine market in China is expected to reach $19.2bn by 2030, with a CAGR of 13-15%.

Surefire Resources (ASX:SRN) produced high grade 4N (99.99%) high purity alumina (HPA) from the Victory Bore vanadium project; “a significant value addition” for any future development.

Sultan Resources (ASX:SLZ) identified multiple pegmatite occurrences up to 30m outcrop and 15m width in early sampling at the Ruddy lithium project in Ontario.

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).